Dova Pharmaceuticals (Dova Pharmaceuticals) Days Inventory : 618.35 (As of Sep. 2019)

View and export this data going back to 2017. Start your Free Trial

What is Dova Pharmaceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Dova Pharmaceuticals's Average Total Inventories for the three months ended in Sep. 2019 was $4.43 Mil. Dova Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2019 was $0.65 Mil. Hence, Dova Pharmaceuticals's Days Inventory for the three months ended in Sep. 2019 was 618.35.

The historical rank and industry rank for Dova Pharmaceuticals's Days Inventory or its related term are showing as below:

DOVA's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 192.335
* Ranked among companies with meaningful Days Inventory only.

Dova Pharmaceuticals's Days Inventory increased from Sep. 2018 (289.04) to Sep. 2019 (618.35). It might indicate that Dova Pharmaceuticals's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Dova Pharmaceuticals's Inventory Turnover for the three months ended in Sep. 2019 was 0.15.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Dova Pharmaceuticals's Inventory-to-Revenue for the three months ended in Sep. 2019 was 1.31.

Dova Pharmaceuticals Days Inventory Historical Data

The historical data trend for Dova Pharmaceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dova Pharmaceuticals Days Inventory Chart

Dova Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Days Inventory

1,357.92

Dova Pharmaceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Days Inventory	Get a 7-Day Free Trial									289.04	967.53	770.75	871.09	618.35

Competitive Comparison of Dova Pharmaceuticals's Days Inventory

For the Biotechnology subindustry, Dova Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dova Pharmaceuticals's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dova Pharmaceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where Dova Pharmaceuticals's Days Inventory falls into.

Dova Pharmaceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Dova Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2018 is calculated as

	Days Inventory (A: Dec. 2018 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2017 )	+	Total Inventories (A: Dec. 2018 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2018 )	*	Days in Period
=	( (0	+	4.39)	/	1 )	/	1.18	*	365
=	4.39					/	1.18	*	365
=	1,357.92

Dova Pharmaceuticals's Days Inventory for the quarter that ended in Sep. 2019 is calculated as:

	Days Inventory (Q: Sep. 2019 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2019 )	+	Total Inventories (Q: Sep. 2019 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2019 )	*	Days in Period
=	( (4.167	+	4.683)	/	2 )	/	0.653	*	365 / 4
=	4.425					/	0.653	*	365 / 4
=	618.35

Dova Pharmaceuticals (NAS:DOVA) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Dova Pharmaceuticals's Inventory Turnover for the three months ended in Sep. 2019 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.653	/	4.425
	=	0.15

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Dova Pharmaceuticals's Inventory to Revenue for the three months ended in Sep. 2019 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	4.425	/	3.373
	=	1.31

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Dova Pharmaceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of Dova Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Dova Pharmaceuticals (Dova Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dova Pharmaceuticals Inc (NAS:DOVA) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

240 Leigh Farm Road, Suite 245, Durham, NC, USA, 27707

Website

http://www.dova.com

Dova Pharmaceuticals Inc is a United States based clinical-stage pharmaceutical company engaged in developing treatments for patients suffering from orphan diseases. It is focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. The company's drug candidate, avatrombopag, is an orally administered thrombopoietin receptor agonist, or TPO-RA, that it is developing for the treatment of thrombocytopenia. The company's drug candidate, avatrombopag, is designed to mimic the effects of thrombopoietin, in vitro and in vivo. Thrombopoietin is a hormone produced in the liver and kidney that binds to its receptor.

Executives

Nancy Wysenski	director	2200 SUNBURST STREET, CHATSWORTH CA 90401
Joseph Edelman	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc	10 percent owner	51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Allen Lee F Md Phd	officer: Chief Medical Officer	C/O AMAG PHARMACEUTICALS, INC., 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR, CAMBRIDGE MA 02140
Roger Jeffs	director
Alfred J Novak	director	325 NE 6TH ST, BOCA RATON FL 33432
David Zaccardelli	director, officer: President & CEO	300 TRI STATE INTERNATIONAL, SUITE 272, LINCOLNSHIRE IL 60069
Paul B Manning	director, 10 percent owner	200 GARRETT STREET SUITE S, CHARLOTTESVILLE VA 22902
Stalfort John A Iii	director	C/O ACUMEN PHARMACEUTICALS, INC., 427 PARK STREET, CHARLOTTESVILLE VA 22902
Jason Hoitt	officer: Chief Commercial Officer	C/O DOVA PHARMACEUTICALS, INC., 240 LEIGH FARM ROAD, SUITE 245, DURHAM NC 27707
Alex Sapir	director, officer: President & CEO	C/O DOVA PHARMACEUTICALS, INC., 240 LEIGH FARM ROAD, SUITE 245, DURHAM NC 27707